• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Dollar's Gain Retailers' Pain
718 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

1952

Everest Medicines
HK$25.10-8.9%58.7%HK$8.1bHK$26.41PS359xE-17.5%n/a

PHIL

Philogen
€17.701.1%15.5%€713.6m€23.00PE2258.2xE30.0%n/a

AMYT

Amryt Pharma
US$14.700.7%86.5%US$940.7mUS$20.75PS3.9xE53.9%n/a

MGNX

MacroGenics
US$15.39-4.2%121.4%US$960.8mUS$24.78PS16.4xE-26.2%n/a

TRDA

Entrada Therapeutics
US$13.5411.0%-16.4%US$431.6mUS$21.00PS3.4xE11.7%n/a

GLPG

Galapagos
€30.75-2.5%-11.5%€2.0b€39.43PS8.5xE-29.0%n/a

A298380

ABL Bio
₩26,200.00-3.5%25.4%₩1.3t₩36,666.67PS19.1xE-73.6%n/a

PRGO

Perrigo
US$31.582.3%-5.2%US$4.2bUS$38.75PB0.9xE47.2%3.5%

NGNE

Neurogene
US$49.2242.4%n/aUS$575.8mUS$53.33PE46.3xE-30.1%n/a

A302440

SK bioscienceLtd
₩62,700.002.3%-10.6%₩4.8t₩56,428.57PE215.7xE-77.1%n/a

AQST

Aquestive Therapeutics
US$4.38-16.6%434.1%US$330.2mUS$9.17PS6.3xE42.4%n/a

BEAM

Beam Therapeutics
US$34.951.0%15.2%US$2.7bUS$49.62PS7.3xE-14.4%n/a

TGTX

TG Therapeutics
US$15.25-0.7%2.3%US$2.2bUS$29.75PE174.2xE49.9%n/a

PROK

ProKidney
US$1.467.4%-86.7%US$343.7mUS$4.20PE-2.7xE-17.0%n/a

ALPN

Alpine Immune Sciences
US$41.6015.9%412.3%US$2.6bUS$45.29PS46.3xE-12.1%n/a

HCM

HUTCHMED (China)
UK£2.765.4%18.2%UK£2.4bUK£4.22PE29.5xE19.0%n/a

CRSP

CRISPR Therapeutics
US$74.503.5%72.7%US$5.9bUS$88.08PS16.1xE37.2%n/a

IMNM

Immunome
US$24.147.6%367.8%US$1.3bUS$33.50PS131.8xE-25.8%n/a

DNLI

Denali Therapeutics
US$21.006.3%-8.3%US$3.0bUS$42.80PS8.8xE8.1%n/a

PRTC

PureTech Health
UK£2.189.7%-3.1%UK£589.1mUK£4.65PS63.5xE-3.8%n/a

KNSA

Kiniksa Pharmaceuticals
US$19.80-2.7%76.3%US$1.4bUS$27.80PE99.3xE-1.5%n/a

VYGR

Voyager Therapeutics
US$9.403.0%25.7%US$562.0mUS$17.25PE3.9xE-41.3%n/a

CRGX

CARGO Therapeutics
US$25.15-10.5%n/aUS$1.1bUS$30.67PE-13xE-3.8%n/a

PNT

POINT Biopharma Global
US$12.500.2%75.1%US$1.3bUS$12.50PE13.8xE9.2%n/a
Page 1 of 30
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.